PL2613776T3 - Kompozycja oraz sposób naprawy i regeneracji mięśni - Google Patents
Kompozycja oraz sposób naprawy i regeneracji mięśniInfo
- Publication number
- PL2613776T3 PL2613776T3 PL11822537T PL11822537T PL2613776T3 PL 2613776 T3 PL2613776 T3 PL 2613776T3 PL 11822537 T PL11822537 T PL 11822537T PL 11822537 T PL11822537 T PL 11822537T PL 2613776 T3 PL2613776 T3 PL 2613776T3
- Authority
- PL
- Poland
- Prior art keywords
- regeneration
- composition
- muscle repair
- muscle
- repair
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37899610P | 2010-09-01 | 2010-09-01 | |
EP11822537.4A EP2613776B1 (en) | 2010-09-01 | 2011-08-31 | Composition and method for muscle repair and regeneration |
PCT/US2011/049905 WO2012030919A2 (en) | 2010-09-01 | 2011-08-31 | Composition and method for muscle repair and regeneration |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2613776T3 true PL2613776T3 (pl) | 2021-01-11 |
Family
ID=45773490
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL20171639T PL3721880T3 (pl) | 2010-09-01 | 2011-08-31 | Kompozycja i sposób naprawy i regeneracji mięśni |
PL11822537T PL2613776T3 (pl) | 2010-09-01 | 2011-08-31 | Kompozycja oraz sposób naprawy i regeneracji mięśni |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL20171639T PL3721880T3 (pl) | 2010-09-01 | 2011-08-31 | Kompozycja i sposób naprawy i regeneracji mięśni |
Country Status (20)
Country | Link |
---|---|
US (5) | US9789074B2 (pl) |
EP (3) | EP3721880B1 (pl) |
JP (1) | JP5986570B2 (pl) |
CN (2) | CN103200937B (pl) |
AU (1) | AU2011296080B2 (pl) |
BR (1) | BR112013004685B1 (pl) |
CA (1) | CA2809374C (pl) |
CL (1) | CL2013000580A1 (pl) |
CO (1) | CO6680694A2 (pl) |
DK (2) | DK2613776T3 (pl) |
EA (1) | EA026251B1 (pl) |
ES (2) | ES2823234T3 (pl) |
HU (2) | HUE059024T2 (pl) |
IL (1) | IL224973B (pl) |
MX (2) | MX361414B (pl) |
NZ (1) | NZ607547A (pl) |
PL (2) | PL3721880T3 (pl) |
PT (1) | PT2613776T (pl) |
WO (1) | WO2012030919A2 (pl) |
ZA (1) | ZA201301536B (pl) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX361414B (es) | 2010-09-01 | 2018-12-05 | Univ Jefferson | Composición y método para reparación y regeneración muscular. |
US11026952B2 (en) | 2011-06-16 | 2021-06-08 | President And Fellows Of Harvard College | Small molecules for mouse satellite cell proliferation |
US11963964B2 (en) | 2011-06-16 | 2024-04-23 | President And Fellows Of Harvard College | Small molecules for mouse satellite cell proliferation |
US9782417B2 (en) | 2011-06-16 | 2017-10-10 | Presidents And Fellows Of Harvard College | Methods of increasing satellite cell proliferation with kinase inhibitors |
MX363111B (es) | 2012-11-08 | 2019-03-08 | Univ Yamaguchi | Agente terapeutico para trastornos de queratoconjuntivitis. |
JP6509126B2 (ja) * | 2013-01-09 | 2019-05-08 | インターナショナル ステム セル コーポレイション | 皮膚の再生を促進する小分子 |
CA2913005C (en) | 2013-05-22 | 2021-08-10 | Yamaguchi University | Inhibitor for retinochoroidal disorders |
EP3152190A4 (en) | 2014-06-04 | 2018-03-28 | Haro Pharmaceutical Inc. | 18-20 member bi-polycyclic compounds |
US9784665B1 (en) * | 2014-12-29 | 2017-10-10 | Flagship Biosciences, Inc. | Methods for quantitative assessment of muscle fibers in muscular dystrophy |
RU2724525C2 (ru) * | 2015-05-06 | 2020-06-23 | Юниверсити Оф Саутерн Калифорния | Способ лечения повышенных уровней инсулина или глюкозы с использованием гипокалорийного или бескалорийного рациона или рациона, имитирующего воздержание от пищи |
EP3091084A1 (en) * | 2015-05-08 | 2016-11-09 | Université Catholique De Louvain | Methods for assessing the purity of a mesenchymal stem cells preparation |
JP2019507186A (ja) * | 2016-02-01 | 2019-03-14 | プレジデント アンド フェローズ オブ ハーバード カレッジ | マウス衛星細胞の増殖のための小分子 |
KR102486607B1 (ko) | 2016-06-08 | 2023-01-11 | 클레멘티아 파마슈티컬즈, 인크. | 이소성 골화를 치료하는 방법 |
SG10202105186XA (en) | 2016-11-16 | 2021-06-29 | Clementia Pharmaceuticals Inc | Methods for treating multiple osteochondroma (mo) |
CA3019069A1 (en) * | 2018-04-02 | 2019-10-02 | Hubit Genomix, Inc. | Prophylactic and/or therapeutic drug for diabetic nephropathy |
WO2023241715A1 (zh) * | 2022-06-16 | 2023-12-21 | 中国科学院动物研究所 | 视黄酸受体激活剂及其组合在哺乳动物再生修复中的应用 |
Family Cites Families (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3270960A (en) | 1964-09-11 | 1966-09-06 | Sperry Rand Corp | Fluid sensor |
US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
JPS60500864A (ja) | 1983-02-04 | 1985-06-06 | ワドリ、テクナラジズ、インコーパレイティド | 近縁関係にあるが別個のタンパク質間に存在する共通決定基に対して特異的なハイブリド−マ抗体の製造および特性づけ |
GB2148299B (en) | 1983-09-01 | 1988-01-06 | Hybritech Inc | Antibody compositions of therapeutic agents having an extended serum half-life |
JPS6253981A (ja) | 1985-09-02 | 1987-03-09 | Koichi Shiyudo | 新規安息香酸誘導体 |
AU618590B2 (en) | 1988-04-11 | 1992-01-02 | Allergan, Inc. | Tetralin esters of phenols or benzoic acids having retinoid like activity |
CA2129773C (en) | 1993-09-02 | 2007-05-01 | Michael Klaus | Aromatic carboxylic acid derivatives |
US5408002A (en) | 1993-09-09 | 1995-04-18 | Minnesota Mining And Manufacturing Company | Azlactone-functional polymer blends, articles produced therefrom and methods for preparing both |
US5498795A (en) | 1994-12-29 | 1996-03-12 | Allergan, Inc. | Acetylenes disubstituted with hydroxyaryl and aryl or heteroaryl groups having retinoid-like biological activity |
US5843780A (en) | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
US5807900A (en) | 1995-03-31 | 1998-09-15 | Hoffmann-La Roche, Inc. | Method for identifying compounds having increased activity for the repair of skin photodamage |
US5624957A (en) | 1995-06-06 | 1997-04-29 | Bristol-Myers Squibb Company | Rary-specific retinobenzoic acid derivatives |
FR2739557B1 (fr) * | 1995-10-09 | 1997-11-14 | Cird Galderma | Utilisation d'un ligand agoniste specifique rar-gamma |
FR2739777B1 (fr) * | 1995-10-11 | 1997-11-14 | Cird Galderma | Ligand antagoniste rar-gamma ou agoniste rar-alpha en tant qu'inhibiteur d'apoptose |
US5726191A (en) | 1995-11-16 | 1998-03-10 | Hoffmann-La Roche Inc. | Aromatic carboxylic acid esters |
US5994619A (en) | 1996-04-01 | 1999-11-30 | University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus | Production of chimeric bovine or porcine animals using cultured inner cell mass cells |
FR2747041B1 (fr) | 1996-04-05 | 1998-05-22 | Cird Galderma | Utilisation de derives benzonaphtaleniques pour la fabrication de medicaments destines au traitement des neuropathies |
US5945577A (en) | 1997-01-10 | 1999-08-31 | University Of Massachusetts As Represented By Its Amherst Campus | Cloning using donor nuclei from proliferating somatic cells |
US5919970A (en) | 1997-04-24 | 1999-07-06 | Allergan Sales, Inc. | Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity |
EP0989855A4 (en) * | 1997-05-13 | 2002-06-12 | Osiris Therapeutics Inc | REGENERATION OF CARTILAGE IN OSTEOARTHRITIS BY MEANS OF HUMAN MESENCHYMAL STEM CELLS |
US7514074B2 (en) | 1997-07-14 | 2009-04-07 | Osiris Therapeutics, Inc. | Cardiac muscle regeneration using mesenchymal stem cells |
DE69936720T2 (de) | 1998-05-29 | 2008-04-30 | Osiris Therapeutics, Inc. | Menschliche cd45+ und/oder fibroblasten+ mesenchymale stammzellen |
AU6056599A (en) | 1998-09-24 | 2000-04-10 | Bristol-Myers Squibb Company | Active enantiomer of rargamma-specific agonist |
JO2178B1 (en) | 1999-10-19 | 2003-04-23 | اف . هوفمان لاروش ايه جي | Treatment of invasive diseases, using selected anti-PAR materials |
US20030114482A1 (en) | 1999-12-15 | 2003-06-19 | Maurizio Pacifici | Use of retinoid receptor antagonists or agonists in the treatment of cartilage and bone pathologies |
US6313168B1 (en) | 1999-12-15 | 2001-11-06 | Allergan Sales, Inc. | Use of retinoid receptor antagonists in the treatment of cartilage and bone pathologies |
US20030125252A1 (en) | 2000-03-14 | 2003-07-03 | Underhill T. Michael | Compositions and methods for affecting osteogenesis |
AU5743601A (en) | 2000-04-28 | 2001-11-12 | Childrens Medical Center | Isolation of mesenchymal stem cells and use thereof |
JP4118675B2 (ja) | 2000-10-02 | 2008-07-16 | エフ.ホフマン−ラ ロシュ アーゲー | 気腫治療用新規レチノイド |
US7087726B2 (en) | 2001-02-22 | 2006-08-08 | Genentech, Inc. | Anti-interferon-α antibodies |
CN1283621C (zh) | 2001-09-18 | 2006-11-08 | 霍夫曼-拉罗奇有限公司 | 烷基脲的类维生素a激动剂ⅰ |
JP4410562B2 (ja) | 2001-09-18 | 2010-02-03 | エフ.ホフマン−ラ ロシュ アーゲー | 置換尿素レチノイド作用薬ii |
AUPR892501A0 (en) * | 2001-11-16 | 2001-12-13 | Peter Maccallum Cancer Institute, The | Method of enhancing self renewal of stem cells and uses thereof |
US7592174B2 (en) | 2002-05-31 | 2009-09-22 | The Board Of Trustees Of The Leland Stanford Junior University | Isolation of mesenchymal stem cells |
RU2004138292A (ru) * | 2002-06-04 | 2005-06-10 | Галдерма Ресерч Энд Девелопмент, С.Н.С. (Fr) | Новые лиганды в качестве ингибиторов рецепторов rar, способы их получения и применение в медицине и косметике для человека |
RU2005102593A (ru) * | 2002-07-03 | 2005-10-10 | Фондационе Чентро Сан Раффаэле Дель Монте Табор (It) | Применение hmgb1 при лечении повреждения ткани и/или для промотирования восстановления ткани |
CA2493871A1 (en) | 2002-07-16 | 2004-01-22 | Hadi Aslan | Methods of implanting mesenchymal stem cells for tissue repair and formation |
US20050101581A1 (en) | 2002-08-28 | 2005-05-12 | Reading Christopher L. | Therapeutic treatment methods 2 |
CA2546054C (en) | 2003-12-10 | 2014-05-13 | Medarex, Inc. | Interferon alpha antibodies and their uses |
JP2005206544A (ja) * | 2004-01-23 | 2005-08-04 | Yasuyoshi Uchida | 筋肉再生剤 |
AU2005240078A1 (en) * | 2004-04-30 | 2005-11-17 | Allergan, Inc. | Retinoid-containing sustained release intraocular drug delivery systems and related methods of manufacturing |
WO2005115304A2 (en) | 2004-05-24 | 2005-12-08 | Ab Science | Use of c-kit inhibitors for treating fibrodysplasia |
US7345931B2 (en) | 2005-08-01 | 2008-03-18 | Infineon Technologies Ag | Maintaining internal voltages of an integrated circuit in response to a clocked standby mode |
FR2894960B1 (fr) | 2005-12-15 | 2008-02-29 | Galderma Res & Dev | Derives biphenyliques agonistes selectifs du recepteurs rar-gamma |
FR2894959B1 (fr) | 2005-12-15 | 2008-02-29 | Galderma Res & Dev | Derives biphenyliques agonistes selectifs du recepteur rar-gamma |
WO2007108272A1 (ja) * | 2006-03-23 | 2007-09-27 | Tmrc Co., Ltd. | 癌治療用キットおよび癌治療用医薬組成物 |
ES2702128T3 (es) | 2006-05-16 | 2019-02-27 | Io Therapeutics Llc | Antagonista o agonista inverso de RAR para uso en el tratamiento de efectos secundarios de quimioterapia y/o terapia de radiación |
US9119777B2 (en) | 2008-05-30 | 2015-09-01 | Microdose Therapeutx, Inc. | Methods and compositions for administration of oxybutynin |
WO2009114180A1 (en) | 2008-03-13 | 2009-09-17 | The General Hospital Corporation | Inhibitors of the bmp signaling pathway |
EP2379174A4 (en) | 2008-12-18 | 2012-11-14 | Astrazeneca Ab | PHARMACEUTICAL PRODUCT USING A P38 KINASE INHIBITOR AND A SECOND ACTIVE SUBSTANCE |
US20120121546A1 (en) * | 2009-02-05 | 2012-05-17 | Vishal Bhasin | Method of Producing Progenitor Cells from Differentiated Cells |
US20120277156A1 (en) | 2009-07-21 | 2012-11-01 | University Of Washington Trhough It's Center For Commercialization | Inhibition of pathological bone formation |
UA50725U (ru) * | 2009-12-01 | 2010-06-25 | Институт Нейрохирургии Им. Акад. А.П. Ромоданова Амн Украины | Способ лечения больных с прогрессирующей мышечной дистрофией трансплантацией миобластов эмбриона человека |
MX361414B (es) | 2010-09-01 | 2018-12-05 | Univ Jefferson | Composición y método para reparación y regeneración muscular. |
US10485780B2 (en) | 2011-03-14 | 2019-11-26 | Beth Israel Deaconess Medical Center, Inc. | Methods and compositions for the treatment of proliferative disorders |
US9464065B2 (en) | 2011-03-24 | 2016-10-11 | The Scripps Research Institute | Compounds and methods for inducing chondrogenesis |
EP2726084A1 (en) | 2011-07-01 | 2014-05-07 | The United States of America, as represented by The Secretary, Department of Health and Human Services | Method of treating pathologic heterotopic ossification |
US9738636B2 (en) | 2012-09-28 | 2017-08-22 | Vanderbilt University | Fused heterocyclic compounds as selective BMP inhibitors |
US20160115167A1 (en) | 2013-03-04 | 2016-04-28 | The Brigham And Women's Hospital, Inc. | Bmp inhibitors and methods of use thereof |
JP6542192B2 (ja) | 2013-03-14 | 2019-07-10 | ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドThe Brigham and Women’s Hospital, Inc. | Bmp阻害剤およびその使用方法 |
CA2913005C (en) | 2013-05-22 | 2021-08-10 | Yamaguchi University | Inhibitor for retinochoroidal disorders |
US20170305883A1 (en) | 2014-10-01 | 2017-10-26 | The Brigham And Women's Hospital, Inc. | Compositions and Methods for Inhibiting BMP |
US20180311356A1 (en) | 2015-10-19 | 2018-11-01 | The Children's Medical Center Corporation | Method to inhibit endothelial-to-mesenchymal transition |
EP3393474B1 (en) | 2015-12-24 | 2023-07-19 | The Regents of The University of Michigan | Method of treating heterotopic ossification |
KR102486607B1 (ko) | 2016-06-08 | 2023-01-11 | 클레멘티아 파마슈티컬즈, 인크. | 이소성 골화를 치료하는 방법 |
JP6630255B2 (ja) | 2016-09-30 | 2020-01-15 | 株式会社沖データ | 画像形成装置及び通信システム |
-
2011
- 2011-08-31 MX MX2013002275A patent/MX361414B/es active IP Right Grant
- 2011-08-31 EA EA201370051A patent/EA026251B1/ru unknown
- 2011-08-31 EP EP20171639.6A patent/EP3721880B1/en active Active
- 2011-08-31 CN CN201180052926.XA patent/CN103200937B/zh active Active
- 2011-08-31 PL PL20171639T patent/PL3721880T3/pl unknown
- 2011-08-31 DK DK11822537.4T patent/DK2613776T3/da active
- 2011-08-31 CN CN202010493245.8A patent/CN111773213B/zh active Active
- 2011-08-31 CA CA2809374A patent/CA2809374C/en active Active
- 2011-08-31 HU HUE20171639A patent/HUE059024T2/hu unknown
- 2011-08-31 WO PCT/US2011/049905 patent/WO2012030919A2/en active Application Filing
- 2011-08-31 PT PT118225374T patent/PT2613776T/pt unknown
- 2011-08-31 EP EP11822537.4A patent/EP2613776B1/en active Active
- 2011-08-31 JP JP2013527250A patent/JP5986570B2/ja active Active
- 2011-08-31 US US13/819,914 patent/US9789074B2/en active Active
- 2011-08-31 ES ES11822537T patent/ES2823234T3/es active Active
- 2011-08-31 AU AU2011296080A patent/AU2011296080B2/en active Active
- 2011-08-31 DK DK20171639.6T patent/DK3721880T3/da active
- 2011-08-31 HU HUE11822537A patent/HUE051664T2/hu unknown
- 2011-08-31 EP EP22154427.3A patent/EP4066826B1/en active Active
- 2011-08-31 PL PL11822537T patent/PL2613776T3/pl unknown
- 2011-08-31 NZ NZ607547A patent/NZ607547A/en unknown
- 2011-08-31 ES ES20171639T patent/ES2912593T3/es active Active
- 2011-08-31 BR BR112013004685-6A patent/BR112013004685B1/pt active IP Right Grant
-
2013
- 2013-02-26 MX MX2018015032A patent/MX2018015032A/es unknown
- 2013-02-28 ZA ZA2013/01536A patent/ZA201301536B/en unknown
- 2013-02-28 IL IL224973A patent/IL224973B/en active IP Right Grant
- 2013-02-28 CL CL2013000580A patent/CL2013000580A1/es unknown
- 2013-03-05 CO CO13044010A patent/CO6680694A2/es not_active Application Discontinuation
-
2014
- 2014-06-18 US US14/308,570 patent/US9314439B2/en active Active
-
2017
- 2017-08-10 US US15/674,357 patent/US10292954B2/en active Active
-
2019
- 2019-04-09 US US16/379,178 patent/US11433039B2/en active Active
-
2022
- 2022-08-04 US US17/881,207 patent/US20230201146A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2613776A4 (en) | COMPOSITIONS AND METHODS FOR MUSCLE REPAIR AND RE-GENERATION | |
ZA201403803B (en) | Composition,apparatus,kit and method and uses thereof | |
SG2014010706A (en) | Method and composition | |
GB201016001D0 (en) | Composition and method | |
HK1200485A1 (en) | Methods and compositions for facilitating regeneration | |
ZA201208578B (en) | Composition,method and use | |
GB201408236D0 (en) | Composition and method | |
GB201122195D0 (en) | Composition and method | |
GB201213490D0 (en) | Method and composition for enhanced hydrocarbons recovery | |
EP2575825A4 (en) | COMPOSITIONS AND METHODS FOR TREATING DEPRESSION | |
ZA201303949B (en) | Compounds and methods for skin repair | |
IL231489A0 (en) | Preparation and method for treating an autoimmune disease | |
EP2632460A4 (en) | COMPOSITIONS AND METHOD FOR THE TREATMENT OF TUBERCULOSIS | |
GB201003531D0 (en) | Composition and method | |
PL392720A1 (pl) | Kompozycja piwa oraz sposób wytwarzania piwa | |
HK1174825A1 (en) | Composition and method for skin repair | |
GB201008843D0 (en) | Method and composition | |
GB201106433D0 (en) | Composition and method | |
GB201008364D0 (en) | Composition and method | |
IL231798A0 (en) | method and preparation | |
EP2617430A4 (en) | COMPOSITION FOR IMPROVING BRAIN FUNCTION AND METHOD FOR IMPROVING BRAIN FUNCTION | |
GB0901667D0 (en) | Composition and method | |
EP2580066A4 (en) | PRINTING METHOD AND PRE-TREATMENT COMPOSITION | |
GB201020439D0 (en) | Method and composition | |
GB201009508D0 (en) | Composition and method |